Osborne Clarke has advised Creo Medical Group plc on the acquisition of Albyn Medical for an equity value of €24.8m. The agreement also included a performance-related…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
